• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


29.864 EUR 0.531 1.81%

As of 06:48:44 ET on 10/24/2014.

Snapshot for Myriad Genetics Inc (MYD)

Open: 29.853 Day's Range: 29.850 - 29.864 Volume: 0
Previous Close: 29.333 52wk Range: 15.025 - 30.865 1-Yr Rtn: +61.59%

Stock Chart for MYD

No chart data available.
  • MYD:GR 29.850
  • 1D
  • 1M
  • 1Y
Interactive MYD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYD

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 19.9825
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) 1.8910
Est. PEG Ratio 1.2906
Market Cap (M EUR) 2,180.01
Shares Outstanding (M) 73.00
30 Day Average Volume 86
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYD

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderRobert Gardner HarrisonChief Information Officer
R Bryan RiggsbeeExec VP/CFO/TreasurerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil